Xuyang Song, PhD, MBA

Xuyang Song, PhD, MBA has worked in a variety of roles in the pharmaceutical industry since 2007. In 2007, they began as a Research Scientist at the University of Florida. In 2012, they became a Summer Intern at Pfizer and a The Oak Ridge Institute for Science and Education (ORISE) Research Fellow at the FDA. In 2013, they were a Summer Student at Uppsala University. From 2014-2022, they held various roles at AstraZeneca, including Director, Clinical and Quantitative Pharmacology, Associate Director (Principal Scientist), Senior Clinical Pharmacokineticist (Associate Principal Scientist), and Clinical Pharmacokineticist. In 2022, they became the Executive Director, Global Head of Clinical Pharmacology at Adlai Nortye Biopharma Co., Ltd.

Xuyang Song, PhD, MBA obtained their Bachelor of Science degree from Shenyang Pharmaceutical University in the College of Business Administration, Pharmaceutics and International Trade. Xuyang then went on to complete a Master of Science degree in Biostatistics from the University of Florida. Following this, they completed a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from the University of Florida. Lastly, they completed a Master of Business Administration - MBA (executive) from the University of Cambridge's Queens College.